VIVS
VIVS
NASDAQ · Biotechnology

Vivosim Labs Inc

$1.32
+0.02 (+1.54%)
As of May 16, 2:32 AM ET ·
Financial Highlights (FY 2026)
Revenue
250.8K
Net Income
-4,332,684
Gross Margin
96.5%
Profit Margin
-1,727.8%
Rev Growth
-54.2%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 96.5% 96.5% 53.9% 53.9%
Operating Margin -8,761.1% -7,885.0% 10.2% 11.9%
Profit Margin -1,727.8% -1,641.4% 12.7% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 250.8K 547.7K 3.56M 2.77M
Gross Profit 242.1K 528.7K 1.92M 1.49M
Operating Income -21,972,863 -43,187,544 363.1K 329.5K
Net Income -4,332,684 -8,515,867 452.9K 261.8K
Gross Margin 96.5% 96.5% 53.9% 53.9%
Operating Margin -8,761.1% -7,885.0% 10.2% 11.9%
Profit Margin -1,727.8% -1,641.4% 12.7% 9.5%
Rev Growth -54.2% -54.2% +0.2% +7.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.21M 2.49M
Total Equity 4.37M 4.42M
D/E Ratio 0.51 0.56
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -4,092,333 -8,490,317 509.0K 375.7K
Free Cash Flow 445.4K 284.4K